HHS proposes 503A enforcement discretion for six peptides
A proposed HHS policy (Federal Register 2026-22192) names BPC-157, TB-500, epitalon, KPV, MOTS-c and semax for 503A compounding enforcement discretion. It is proposed, not final, and is not FDA approval.
Peptides: BPC-157, TB-500, Epithalon, KPV, MOTS-c, Semax
Primary source: Federal Register 2026-22192
Full explainer: HHS 503A peptide notice (2026)
Get an email when a peptide's status changes
We email you when the FDA or HHS makes a move on a peptide you care about. Every email links the official source. No spam, no sales.
We don't collect health information. Unsubscribe anytime. Privacy policy